159 related articles for article (PubMed ID: 29937457)
1. Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease.
Hori Y; Nakamura K; Kanno N; Hitomi M; Yamashita Y; Hosaka S; Isayama N; Mimura T
J Vet Med Sci; 2018 Aug; 80(8):1212-1218. PubMed ID: 29937457
[TBL] [Abstract][Full Text] [Related]
2. Effects of high-dose alacepril on left atrial pressure and central aortic pressure in awake dogs with mitral valve regurgitation.
Goya S; Wada T; Shimada K; Hirao D; Tanaka R
Vet J; 2019 Mar; 245():7-11. PubMed ID: 30819428
[TBL] [Abstract][Full Text] [Related]
3. The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation.
Ishikawa T; Tanaka R; Suzuki S; Miyaishi Y; Akagi H; Iino Y; Fukushima R; Yamane Y
J Vet Intern Med; 2010; 24(2):342-7. PubMed ID: 20102507
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
[TBL] [Abstract][Full Text] [Related]
5. Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure.
Kinugawa T; Osaki S; Kato M; Ogino K; Shimoyama M; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
Clin Exp Pharmacol Physiol; 2002 Dec; 29(12):1060-5. PubMed ID: 12390293
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.
Sakatani A; Miyagawa Y; Takemura N
J Vet Cardiol; 2016 Sep; 18(3):248-254. PubMed ID: 27364087
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of mitral valve insufficiency in dogs with the ACE inhibitor enalapril. A clinical progress study].
Biller B; Hörauf A; Kraft W
Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Feb; 26(1):21-30. PubMed ID: 9531670
[TBL] [Abstract][Full Text] [Related]
8. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
[TBL] [Abstract][Full Text] [Related]
9. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
[TBL] [Abstract][Full Text] [Related]
10. Effect of pimobendan on echocardiographic values in dogs with asymptomatic mitral valve disease.
Ouellet M; Bélanger MC; Difruscia R; Beauchamp G
J Vet Intern Med; 2009; 23(2):258-63. PubMed ID: 19143935
[TBL] [Abstract][Full Text] [Related]
11. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
Pouchelon JL; Jamet N; Gouni V; Tissier R; Serres F; Carlos Sampedrano C; Castaignet M; Lefebvre HP; Chetboul V
J Vet Intern Med; 2008; 22(4):905-14. PubMed ID: 18482278
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency.
Kitagawa H; Wakamiya H; Kitoh K; Kuwahara Y; Ohba Y; Isaji M; Iwasaki T; Nakano M; Sasaki Y
J Vet Med Sci; 1997 Jul; 59(7):513-20. PubMed ID: 9271444
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
[TBL] [Abstract][Full Text] [Related]
14. [ACE inhibitors in dogs with subclinical chronic mitral insufficiency].
Kvart C; Häggström J; Pedersen HD
Tijdschr Diergeneeskd; 2003 Feb; 128(3):76-7. PubMed ID: 12616901
[No Abstract] [Full Text] [Related]
15. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
[TBL] [Abstract][Full Text] [Related]
16. Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study.
Chetboul V; Lefebvre HP; Sampedrano CC; Gouni V; Saponaro V; Serres F; Concordet D; Nicolle AP; Pouchelon JL
J Vet Intern Med; 2007; 21(4):742-53. PubMed ID: 17708394
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
[TBL] [Abstract][Full Text] [Related]
18. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group.
J Vet Intern Med; 1995; 9(4):234-42. PubMed ID: 8523320
[TBL] [Abstract][Full Text] [Related]
19. Chordae tendineae rupture in dogs with degenerative mitral valve disease: prevalence, survival, and prognostic factors (114 cases, 2001-2006).
Serres F; Chetboul V; Tissier R; Sampedrano CC; Gouni V; Nicolle AP; Pouchelon JL
J Vet Intern Med; 2007; 21(2):258-64. PubMed ID: 17427386
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease.
Chetboul V; Serres F; Tissier R; Lefebvre HP; Sampedrano CC; Gouni V; Poujol L; Hawa G; Pouchelon J-
J Vet Intern Med; 2009; 23(5):984-94. PubMed ID: 19572913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
